144 related articles for article (PubMed ID: 8676203)
1. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies.
Schneiderman MH; Schneiderman GS
J Nucl Med; 1996 Apr; 37(4 Suppl):6S-9S. PubMed ID: 8676203
[TBL] [Abstract][Full Text] [Related]
2. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
Kassis AI; Adelstein SJ; Mariani G
Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
[TBL] [Abstract][Full Text] [Related]
4. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
[TBL] [Abstract][Full Text] [Related]
5. Preclinical animal studies with radioiododeoxyuridine.
Kassis AI; Adelstein SJ
J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
[TBL] [Abstract][Full Text] [Related]
6. Iododeoxyuridine uptake in proliferating smooth muscle cells in vitro.
Xu Y; Jagtap MR; Garland T; Ying J; McGarry RC; Mendonca MS; McLennan G
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):73-8. PubMed ID: 17296707
[TBL] [Abstract][Full Text] [Related]
7. Molecular suicide studies of 125I and 3H disintegration in the DNA of Chinese hamster cells.
Burki HJ; Koch C; Wolff S
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):408-25. PubMed ID: 565272
[TBL] [Abstract][Full Text] [Related]
8. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site of radiation damage.
Warters RL; Hofer KG; Harris CR; Smith JM
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):389-407. PubMed ID: 565271
[TBL] [Abstract][Full Text] [Related]
9. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
10. Inhomogeneity of the nucleus to 125IUdR cytotoxicity.
Yasui LS; Hofer KG; Warters RL
Radiat Res; 1985 Apr; 102(1):106-18. PubMed ID: 3920724
[TBL] [Abstract][Full Text] [Related]
11. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled iododeoxyuridine: safety evaluation.
Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
[TBL] [Abstract][Full Text] [Related]
14. Enhanced IUdR radiosensitization by 241Am photons relative to 226Ra and 125I photons at 0.72 Gy/hr.
Nath R; Bongiorni P; Rossi PI; Rockwell S
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1377-85. PubMed ID: 2370187
[TBL] [Abstract][Full Text] [Related]
15. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
[TBL] [Abstract][Full Text] [Related]
17. Optimal photon energies for IUdR K-edge radiosensitization with filtered x-ray and radioisotope sources.
Karnas SJ; Yu E; McGarry RC; Battista JJ
Phys Med Biol; 1999 Oct; 44(10):2537-49. PubMed ID: 10533927
[TBL] [Abstract][Full Text] [Related]
18. Radiotoxicity of 125I in mammalian cells.
Kassis AI; Fayad F; Kinsey BM; Sastry KS; Taube RA; Adelstein SJ
Radiat Res; 1987 Aug; 111(2):305-18. PubMed ID: 3628718
[TBL] [Abstract][Full Text] [Related]
19. Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates.
Nath R; Bongiorni P; Rockwell S
Radiat Res; 1990 Dec; 124(3):249-58. PubMed ID: 2263725
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
